Macedonia

 

Acibadem eyes up UK opportunities

IHH-owned Turkish hospital group Acibadem has opened a contact centre in the Harley Street medical area in the UK and has an eye on market opportunities. HBI speaks to an operator and an advisor to find out more.

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?

CEE – a land of opportunity?

With 125 million people - 80 million of whom live in the big four (Poland, Romania, Czechia and Hungary) - CEE is a large and diverse market. But is it a tempting one? HBI-365 members heard an expert panel in our CEE State of the Regions broadcast suggest that while COVID is creating huge problems across the world, it is also creating opportunities in Central and Eastern Europe.

Interview: Arjan Toor, CEO, Cigna Europe

Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.

Full year post-tax profits plummet at IHH

Pan-Asian hospital group IHH Healthcare saw 3% revenue growth, 9% EBITDA growth but a 35% plummet in post-tax profits in 2018. The results confirm its struggles in Turkey.

Diaverum enters Macedonia

Soon-to-sell global dialysis service provider Diaverum has bought Macedonia's largest operator, with the CEO adding it could be a platform for further expansion in the region. We talk to Diaverum, dig further into the Macedonian dialysis market and disclose the revenue of the acquired company.

Is IHH pulling out of Europe?

Recent developments point to pan-Asian hospital group IHH scaling down Acibadem, its Turkey-based subsidiary. What does this mean for its interest in Europe? We talk to well-placed sources about what a falling lira, shareholder restructuring, asset sales in Bulgaria and Macedonia, and IHH's acquisition of Indian chain Fortis might mean.

Find Us